Directorio

We are doing this study to find the safest and most effective dose of an experimental drug called ZL-1310 (the study drug). We want to know if this drug can be beneficial for people with small cell lung cancer (SCLC) that progressed after at least one round of chemotherapy.

We are doing this study to find the most effective, safe dose of an experimental drug called zanzalintinib (the study drug). We want to know how well it works in combination with pembrolizumab when it is given to people who have recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

We are doing this study to find out what the safest and most effective dose of the study drug (ZN-A-1041) is when given alone or in combination with capecitabine.